Sleep and interstitial lung disease
PURPOSE OF REVIEW: There is an increasing recognition of the impact of sleep and sleep disorders on respiratory disease. Recent years have seen a new focus on the relationship between sleep and outcomes in patients interstitial lung disease (ILD).
RECENT FINDINGS: Recent studies suggest a high prevalence of sleep issues in ILD cohorts, which seem to have a meaningful negative impact on quality of life, disease progression, and survival.
SUMMARY: Sleep disordered breathing is common in ILD patients: obstructive sleep apnoea (OSA) is found in 44-72% of ILD patients, and nocturnal hypoxemia is relatively common even in the absence of OSA. Sleep disorders are associated with worse quality of life in ILD, and may also predict more rapid disease progression and increased mortality. It remains unknown if nocturnal hypoxemia may itself cause progression of ILD. Uncontrolled and retrospective studies have suggested that treating OSA may improve ILD-related outcomes, but prospective studies are lacking in this field.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
|---|---|
| Enthalten in: |
Current opinion in pulmonary medicine - 25(2019), 6 vom: 16. Nov., Seite 623-628 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Myall, Katherine J [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 19.06.2020 Date Revised 19.06.2020 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1097/MCP.0000000000000620 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM301120196 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM301120196 | ||
| 003 | DE-627 | ||
| 005 | 20231225103954.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/MCP.0000000000000620 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1003.xml |
| 035 | |a (DE-627)NLM301120196 | ||
| 035 | |a (NLM)31503213 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Myall, Katherine J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Sleep and interstitial lung disease |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.06.2020 | ||
| 500 | |a Date Revised 19.06.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a PURPOSE OF REVIEW: There is an increasing recognition of the impact of sleep and sleep disorders on respiratory disease. Recent years have seen a new focus on the relationship between sleep and outcomes in patients interstitial lung disease (ILD) | ||
| 520 | |a RECENT FINDINGS: Recent studies suggest a high prevalence of sleep issues in ILD cohorts, which seem to have a meaningful negative impact on quality of life, disease progression, and survival | ||
| 520 | |a SUMMARY: Sleep disordered breathing is common in ILD patients: obstructive sleep apnoea (OSA) is found in 44-72% of ILD patients, and nocturnal hypoxemia is relatively common even in the absence of OSA. Sleep disorders are associated with worse quality of life in ILD, and may also predict more rapid disease progression and increased mortality. It remains unknown if nocturnal hypoxemia may itself cause progression of ILD. Uncontrolled and retrospective studies have suggested that treating OSA may improve ILD-related outcomes, but prospective studies are lacking in this field | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a West, Alex |e verfasserin |4 aut | |
| 700 | 1 | |a Kent, Brian D |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current opinion in pulmonary medicine |d 1995 |g 25(2019), 6 vom: 16. Nov., Seite 623-628 |w (DE-627)NLM090955196 |x 1531-6971 |7 nnns |
| 773 | 1 | 8 | |g volume:25 |g year:2019 |g number:6 |g day:16 |g month:11 |g pages:623-628 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1097/MCP.0000000000000620 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 25 |j 2019 |e 6 |b 16 |c 11 |h 623-628 | ||